{
    "clinical_study": {
        "@rank": "19901", 
        "arm_group": [
            {
                "arm_group_label": "Withou Diabetic Nephropathy", 
                "description": "Patients who have persistent normoalbuminuria (<30 mg/g creatinine or <20 \u03bcg/min)."
            }, 
            {
                "arm_group_label": "Incipient Nephropathy", 
                "description": "Patients who have persistent microalbuminuria (30-300 mg/g creatinine or 20-200 \u03bcg/min)."
            }, 
            {
                "arm_group_label": "Overt Diabetic Nephropathy", 
                "description": "Patients who have persistent macroalbuminuria (>300 mg/g creatinine or >200 \u00b5g/min), proteinuria (>500 mg/24 h) or renal replacement therapy."
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole Blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Cells damaged by hyperglycemia are unable to downregulate glucose entrance in presence of\n      high extracellular glucose resulting in intracellular activation of deleterious biochemical\n      pathways. Expression of GLUT-1, the major glucose transporter in mesangial cells, is\n      increased and participates in the induction of diabetic nephropathy. Variants in the gene\n      encoding GLUT-1 (SLC2A1) have been associated to this diabetic complication. The aim of this\n      study was to test whether polymorphisms in SLC2A1 confer susceptibility to diabetic\n      nephropathy in Brazilian type 1 diabetes patients."
        }, 
        "brief_title": "SLC2A1 Variants and Diabetic Nephropathy", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Diabetic Nephropathy.", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 1", 
                "Diabetic Nephropathies", 
                "Kidney Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study, 449 patients, included between October 2004 and October 2012, were sorted\n      into three groups according to diabetic nephropathy stages: without (persistent\n      normoalbuminuria, n=248), incipient (microalbuminuria, n=82) and overt diabetic nephropathy\n      (macroalbuminuria or proteinuria or renal replacement therapy, n=119). Measurements of\n      urinary albumin-to-creatinine ratio (ACR) or urinary albumin excretion rate (UAER) were used\n      to define DN: patients with persistent normoalbuminuria (<30 mg/g creatinine or <20 \u03bcg/min)\n      were classified as without DN (n=248); patients presenting persistent microalbuminuria\n      (30-300 mg/g creatinine or 20-200 \u03bcg/min) were classified as having incipient DN (n=82); and\n      patients presenting persistent macroalbuminuria (>300 mg/g creatinine or >200 \u00b5g/min),\n      proteinuria (>500 mg/24 h) or renal replacement therapy were classified as having overt DN\n      (n=119). Genotyping of polymorphisms was performed by Real Time PCR using fluorescent\n      -labelled probes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Overt 10 years of Diabetes Mellitus\n\n        Exclusion Criteria:\n\n          -  Patients presenting autoimmune diseases, HIV or HCV infections\n\n          -  Patients with glomerular filtration rate < 60 mL min\u22121 1.73 m2 without diabetic\n             retinopathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "11 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "449 patients with type 1 diabetes (56.4% female, mean age 36.0\u00b111.0 years) were included\n        between October 2004 and October 2012. Inclusion criterion was type 1 diabetes duration\n        \u226510 years. The patients presented a mixed ethnic background (European Caucasian, African,\n        Amerindian and Asian of several different countries of origin), which reflects the\n        Brazilian population."
            }
        }, 
        "enrollment": {
            "#text": "449", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01768611", 
            "org_study_id": "FMUSP-LIM25-001"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "01246-000"
                }, 
                "name": "Faculdade de Medicina da USP"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_groups": "3", 
        "official_title": "Association of Single Nucleotide Polymorphisms in the Gene Coding GLUT-1 and Diabetic Nephropathy in Brazilian Patients With Type 1 Diabetes Mellitus", 
        "overall_official": {
            "affiliation": "Hospital Cl\u00ednicas/Faculdade de Medicina da USP", 
            "last_name": "Maria L C\u00f4rrea-Giannela, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Plasmatic Creatinine", 
            "safety_issue": "No", 
            "time_frame": "Two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01768611"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Sao Paulo General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2004", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}